Inactive Instrument

Other languages INSTEM

Equities

Instem and Proscia Partners to Accelerate Preclinical Development with Digital Pathology	Jun. 17
Instem Enables Clients to Leverage ICH S1B Weight of Evidence Guideline	Jan. 25
Instem plc Announces Board Resignations	Nov. 20
ArchiMed SAS agreed completed the acquisition of Instem plc (AIM : INS) from group of sellers.	Nov. 19
Instem acquisition by Ichor sanctioned by UK court	Nov. 16
Actual Experience appoints administrators	Nov. 07
Instem's Acquisition by Archimed's Ichor Management Granted UK Regulatory Nod	Nov. 07
Instem shareholders back motions relating to Archimed offer	Nov. 03
Instem adjourns meeting after disclosing further approaches	23-10-18
Instem shares fall back as Archimed says offer is final	23-10-13
AIM WINNERS & LOSERS: TomCo raises funds; Instem bid "final"	23-10-13
Instem's second-largest shareholder opposes deal with PE firm Archimed	23-09-28
Instem swings to loss in first half but posts revenue growth	23-09-15
Instem plc Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-15
Actualización de las fuertes variaciones del día: Instem, Stadler Rail, Aroundtown, Orsted, Brunello Cucinelli, Prudential, y otras	23-08-30
FTSE 100 outperforms European peers	23-08-30
Les actions en mouvement : chaos au Gabon et plongeon au Danemark	23-08-30
AIM WINNERS & LOSERS: Instem soars on GBP200 million takeover	23-08-30
Prudential outperforms; Instem jumps on takeover	23-08-30
Instem Jumps 40% on GBP203 Million Takeover Offer from Archimed	23-08-30

No results for this search